Skip to main content

Table 1 Number of differentially expressed proteins

From: 4D label-free proteomics analysis of oxygen-induced retinopathy with or without anti-VEGF treatment

Compared samples

Num. of total quant

Regulated type

FC > 1.2

FC > 1.3

FC > 1.5

FC > 2.0

Group A vs. Group B

4329

up-regulated

371

309

198

81

down-regulated

56

48

34

21

Group B vs. Group C

4019

up-regulated

1465

1458

1439

1284

down-regulated

68

65

61

45

Group A vs. Group C

3976

up-regulated

1236

1232

1217

1080

down-regulated

57

57

53

37

  1. Group A: the ranibizumab group, Group B: the OIR group, Group C: the normal group
  2. Num. of Total Quant. Number of total quantifiable proteins, FC Fold-change